Short answer
Privia Health Group, Inc. (PRVA) filed an 8-K current report with the SEC on August 18, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item EX-99.1 (Exhibit EX-99.1). Opella Ernest, M.D. joins Privia Health’s Board as an independent Class III director effective September 1, 2026.
Privia Health Group, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Opella Ernest, M.D. joins Privia Health’s Board as an independent Class III director effective September 1, 2026
- Compliance Committee appointment adds physician expertise to board oversight
- Annual director equity grant carries $200,000 grant-date fair value in restricted stock units
- Initial equity grant prorated through the next annual stockholders meeting
- No disclosed related-party transactions or selection arrangements involving Dr. Ernest
Item EX-99.1 · Exhibit EX-99.1
- Opella Ernest, M.D. appointed director effective September 1, 2026
- Compliance Committee appointment strengthens clinical and value-based care oversight
- Over 20 years of healthcare executive experience, including HCSC market leadership since 2023
- Board expertise supports Privia’s expansion of scaled provider networks across 25 states and District of Columbia
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Privia Health Group, Inc. 8-K filings
Get the next PRVA 8-K as it lands
Follow PRVA for push alerts, or ask the research agent what this filing means.